Moreover, we identified CX3CR1 as a potentially novel peripheral marker of tauopathy, suggesting parallel changes in CX3CR1 in microglia and peripheral leukocytes in the course of tau-mediated neurodegeneration. Here, MAPT is linked to tauopathy.